CI vs NEPH · P/E 2.4, rev $274.90B vs P/E 48, rev $14.2M
Cigna Corp (CI) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
CI currently screens at market cap $71.62B and trailing P/E 2.4. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Not investment advice. Open the CI and NEPH stock pages for the full models.
Not investment advice.